RxDoctor Payments Data

Dagoberto Heredia

Psychiatry · Lawrence, KSNPI 1558395467

Payments from drug & device makers

$1,528in general payments, 2019–2025

Across 82 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$409
  • Vanda Pharmaceuticals Inc.$251
  • Takeda Pharmaceuticals U.S.A., Inc.$127
  • Ironshore Pharmaceuticals Inc.$109
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$85
  • Teva Pharmaceuticals USA, Inc.$70
  • plus $477 from 19 others

What the payments were for

  • Food & beverage$1,46996%
  • Education$604%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,528 in reported general payments places this provider in the 70th percentile of 259 psychiatry providers in Kansas.

See all psychiatry providers in Kansas

Medicare billing

Part B allowed, 2024
$8,458
Medicare patients
20
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate91$277,771
Abilify MaintenaAripiprazole17$49,508
VraylarCariprazine Hcl14$19,411
Aripiprazole113$12,123
Paliperidone ErPaliperidone28$11,603
Clozapine76$8,444
TrintellixVortioxetine Hydrobromide14$7,927
Quetiapine Fumarate ErQuetiapine Fumarate40$4,839
Lurasidone Hcl19$4,775
Ziprasidone Hcl57$4,518
Olanzapine114$4,478
Memantine Hcl64$3,284
Duloxetine Hcl182$3,207
Trazodone Hcl284$3,102
Haloperidol65$3,012

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$25$277,77191 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$17$49,50817 claims
AbbVieVraylar$409$19,41114 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$127$7,92714 claims
Lilly USA, LLCOlanzapine$27$4,478114 claims
Teva Pharmaceuticals USA, Inc.Loxapine$70$49712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 259 psychiatry providers in Kansas.

Other psychiatry in Lawrence

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →